z-logo
open-access-imgOpen Access
Trametes versicolor mushroom immune therapy in breast cancer.
Author(s) -
Leanna J Standish,
Cynthia A Wenner,
Erin S Sweet,
Carly Bridge,
Ana Nelson,
Mark Martzen,
Jeffrey Novack,
Carolyn Torkelson
Publication year - 2008
Publication title -
journal of the society for integrative oncology
Language(s) - English
DOI - 10.2310/7200.2008.0016
Data from multiple epidemiologic and clinical studies on immune effects of conventional cancer treatment and the clinical benefits of polysaccharide immune therapy suggest that immune function has a role in breast cancer prevention. Immune therapy utilizing the polysaccharide constituents of Trametes versicolor (Tv) as concurrent adjuvant cancer therapy may be warranted as part of a comprehensive cancer treatment and secondary prevention strategy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom